Mashup Score: 1
TwitterSo excited to present initial results of Patriot-II study at #GU23 @ASCO thankful to patients, all investigators/st… https://t.co/pgw42ChPnh
See more from Petros Grivas
We presented the initial findings from the PATRIOT-II study looking at real world data on first line therapy in advanced urothelial Ca with induction chemo followed by switch maintenance avelumab in patients without progression